{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:13:27Z","timestamp":1793643207991,"version":"4.5.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.beem.2021.101505","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:35:27Z","timestamp":1613608527000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Quality of life in Cushing\u2019s syndrome"],"prefix":"10.1016","volume":"35","author":[{"given":"Margot Mc","family":"Bride","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2021.101505_bib1","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2021.101505_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptative personality traits after long cure of Cushing\u2019s syndrome","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"ERCUSYN Study Group. The European Registry on Cushing\u2019s Syndome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","article-title":"Clinical consequences of Cushing\u2019s syndrome","volume":"15","author":"Valassi","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing\u2019s disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib7","author":"Crispin"},{"key":"10.1016\/j.beem.2021.101505_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00435734","article-title":"Study protocol for the World health organization project to develop a quality of life assessment instrument (WHOQOL)","volume":"2","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.beem.2021.101505_bib9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0277-9536(95)00116-O","article-title":"Clinical and public health perspectives and applications of health-related quality of life measurement","volume":"41","author":"Ebrahim","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.beem.2021.101505_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cen.13719","article-title":"Quality of life in patients with adrenal diseases: a systematic review","volume":"89","author":"Ho","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00862","article-title":"Quality of life in patients with Cushing\u2019s disease","volume":"10","author":"Santos","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ando.2018.03.007","article-title":"Quality of life in Cushing\u2019s disease: a long-term issue?","volume":"79","author":"Webb","year":"2018","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EJE-12-0325","article-title":"Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice","volume":"167","author":"Santos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of Health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","article-title":"The development of the Tuebingen Cushing\u2019s disease quelity of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000431022","article-title":"Validation of the Tuebingen CD-25 inventory as a measure of postoperative Health-realted quality of life in patients treated for Cushing\u2019s disease","volume":"102","author":"Milian","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2021.101505_bib17","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2020.3.FOCUS2044","article-title":"Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing\u2019s disease","volume":"48","author":"Cusimano","year":"2020","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.beem.2021.101505_bib18","first-page":"1","article-title":"Evaluating patient-based outcome measures for use in clinical trials","volume":"2","author":"Fitzpatrick","year":"1998","journal-title":"Health Technol Assess (Winchester, Engl)"},{"key":"10.1016\/j.beem.2021.101505_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","article-title":"Psychiatric disorders associated with Cushing\u2019s syndrome: epidemiology, pathophysiology and treatment","volume":"15","author":"Sonino","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.beem.2021.101505_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","article-title":"Vance ML Quality of life in patients with a pituitary adenoma","volume":"6","author":"Johnson","year":"2003","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","article-title":"Cushing\u2019s syndrome from the patient perspective","volume":"23","author":"Gotch","year":"1994","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2021.101505_bib22","first-page":"287","article-title":"Sexual function in women with Cushing\u2019s syndrome: a controlled study","volume":"44","author":"Keskin","year":"2018","journal-title":"Turk J Urol"},{"key":"10.1016\/j.beem.2021.101505_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11102-018-0913-3","article-title":"Work disability and its determinants in patients with pituitary tumor-related disease","volume":"21","author":"Lobatto","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term impaired quality of life in Cushing\u2019s syndrome despite clinical improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fendo.2018.00368","article-title":"Assessing differences in how the CushingQoL is interpreted across countries: comparing patients from the US and The Netherlands","volume":"9","author":"Winter","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1530\/EJE-12-1078","article-title":"A\u00a0direct comparison of quality in obese and Cushing\u2019s syndrome patients","volume":"168","author":"Abraham","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib27","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease","volume":"90","author":"Van Aken","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary orif\u00a1gin;a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib29","first-page":"5325","article-title":"Improvement but no normalization of quality of life and cognitive functioning after treatment of Cushing\u2019s syndrome","volume":"104","author":"Broersen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/cen.13600","article-title":"Worse health-related quality of life at long-term follow-up in patients with Cushing\u2019s disease than patients with cortisol producing adenoma. Data from the ERCUSYN","volume":"88","author":"Valassi","year":"2018","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.beem.2021.101505_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","article-title":"Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib32","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-17-0041","article-title":"Quality of life tools for the management of pituitary disease","volume":"177","author":"Webb","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib33","doi-asserted-by":"crossref","first-page":"1054s1061","DOI":"10.1016\/j.surg.2008.08.024","article-title":"Waiting for change: symptom resolution after adrenalectomy for Cushing\u2019s syndrome","volume":"144","author":"Sippel","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2021.101505_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12020-018-1664-7","article-title":"Lack of functional remission in Cushing\u2019s syndrome","volume":"61","author":"Vermalle","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2021.101505_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/cen.12521","article-title":"Predictors of quality of life in 102 patients with treated Cushing\u2019s disease","volume":"82","author":"Carluccio","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2010-2490","article-title":"Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas","volume":"96","author":"Tiemensma","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-11-0307","article-title":"Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing\u2019s syndrome","volume":"165","author":"Tiemensma","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","article-title":"Bilateral adrenalectomy for refractory Cushing\u2019s disease: a safe and definitive therapy","volume":"208","author":"Smith","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.beem.2021.101505_bib39","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-16-0815","article-title":"Increased prevalence of obstructive sleep apnea in patients with Cushing\u2019s syndrome compared with weight-and age- matched controls","volume":"176","author":"Gokosmanoglu","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib42","series-title":"Muscle Dysfunction is Associated With Poor Quality of Life in Patients With Cushing\u2019s Syndrome Long-Term After remission","author":"Martel","year":"2019"},{"key":"10.1016\/j.beem.2021.101505_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing\u2019s syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2021.101505_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP15855.OR","article-title":"Patients\u2019 perception on clinical outcome and quality of life after a diagnosis of Cushing\u2019s syndrome","volume":"22","author":"Papoian","year":"2016","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2021.101505_bib45","doi-asserted-by":"crossref","first-page":"dgz136","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing\u2019s syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib46","doi-asserted-by":"crossref","first-page":"9014768","DOI":"10.1155\/2018\/9014768","article-title":"Support needs of patients with Cushing\u2019s disease and Cushing\u2019s syndrome: results of a survey conducted in Germany and the USA","volume":"2018","author":"Kreitschmann-Andermahr","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-17-0048","article-title":"Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulation: a cohort study","volume":"177","author":"De Bucy","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002689910020","article-title":"Long-term results of total adrenalectomy for Cushing\u2019s disease","volume":"24","author":"Nagesser","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2021.101505_bib49","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","article-title":"Improved quality of life after bilateral adrenalectomy for Cushingt\u2019s disease: a 10-year experience","volume":"245","author":"Thompson","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2021.101505_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-14-0214","article-title":"Favorable long-term outcomes of bilateral adrenalectomy in Cushing\u2019s disease","volume":"171","author":"O\u00dfwald","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib51","doi-asserted-by":"crossref","first-page":"dgaa291","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with Cushing\u2019s disease during long-term remission: a Swedish Nationwide Study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101505_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.2003.01799.x","article-title":"Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects","volume":"59","author":"Malik","year":"2003","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.beem.2021.101505_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","article-title":"Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib54","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1210\/jc.2014-3632","article-title":"Time to recovery of adrenal function after curative surgery for Cushing\u2019s syndrome depends on etiology","volume":"100","author":"Berr","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing\u2019s syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2021.101505_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2015.00129","article-title":"Neuropsychiatric disorders in Cushing\u2019s syndrome","volume":"9","author":"Pivonello","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.beem.2021.101505_bib58","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-14-1101","article-title":"Mechanisms in endocrinology: Cushing\u2019s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies","volume":"173","author":"Andela","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.beem.2021.101505_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0090-3019(99)00197-4","article-title":"Crerebral atrophy in Cushing\u2019s disease","volume":"53","author":"Simmons","year":"2000","journal-title":"Surg Neurol"},{"key":"10.1016\/j.beem.2021.101505_bib61","doi-asserted-by":"crossref","first-page":"2061935","DOI":"10.1155\/2017\/2061935","article-title":"Depression and anxiety scores are associated with amygdala volume in Cushing\u2019s syndrome: preliminary study","volume":"2017","author":"Santos","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.beem.2021.101505_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-14-0371","article-title":"Small cerebellar cortex volume in patients with active Cushing\u2019s syndrome","volume":"171","author":"Santos","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing\u2019s disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology"},{"key":"10.1016\/j.beem.2021.101505_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","article-title":"Depressed mood and other psychiatric manifestations of Cushing\u2019s syndrome: relationship to hormone levels","volume":"43","author":"Starkman","year":"1981","journal-title":"Psychosom Med"},{"key":"10.1016\/j.beem.2021.101505_bib65","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","article-title":"A\u00a0prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome","volume":"45","author":"Kelly","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/joim.13056","article-title":"Psychiatric and neurocognitive consequences of endogenous hypercortisolism","volume":"288","author":"Piasecka","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2021.101505_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-16-0779","article-title":"Affective alterations in patients with Cushing\u2019s syndrome in remission are associated with decreased BDNF and cortisone levels","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/EJE-11-0749","article-title":"Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex","volume":"166","author":"Brummelman","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib70","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s11102-015-0653-6","article-title":"Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas","volume":"18","author":"Lecumberri","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-13-1013","article-title":"Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing\u2019s disease","volume":"171","author":"Webb","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib72","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/ERC-12-0191","article-title":"Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease","volume":"19","author":"van der Pas","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2021.101505_bib73","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib74","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(19)30313-4","article-title":"Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing\u2019s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial","volume":"7","author":"Fleseriu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib75","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC3): a multicentre phase III study with a double \u2013blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib76","doi-asserted-by":"crossref","first-page":"E1802","DOI":"10.1210\/jc.2014-1906","article-title":"Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing\u2019s syndrome in remission","volume":"99","author":"Ragnarsson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2021.101505_bib77","doi-asserted-by":"crossref","first-page":"44445","DOI":"10.1038\/srep44445","article-title":"Reduced DNA methylation and psychopathology following endogenous hypercortisolism. A genome-wide study","volume":"7","author":"Glad","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101505_bib78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11102-014-0561-1","article-title":"Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL","volume":"18","author":"Andela","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2021.101505_bib79","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-20-0652","article-title":"Evaluation of an individualized education program in pituitary diseases: a pilot study","volume":"183","author":"Albarel","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-16-1015","article-title":"Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial","volume":"177","author":"Andela","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101505_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-015-0737-0","article-title":"A\u00a0specific nursing educational program in patients with Cushing\u2019s syndrome","volume":"53","author":"Mart\u00ednez-Mombl\u00e1n","year":"2016","journal-title":"Endocrine"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:01Z","timestamp":1761497761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1521690X21000221"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101505","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life in Cushing\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101505"}}